BIOBOT SURGICAL

TECHNOLOGY

1. Joint IP with SingHealth & National Technological University of Singapore
2. Used for transperineal prostate biopsy & focal therapy

TRANSLATION SCOPE

1. Design for manufacturing, assembly and testing
2. Establish manufacturing processes in line with standards
3. Assist in regulatory submissions

TRANSLATION OUTCOME

1. Accuracy +/- 1mm (vs conventional +/- 10mm)
2. Doubled detection rate of prostate cancer
3. FDA, CE, HSA, TGA, DOH approved
4. Completed more than 550 clinical cases with Singapore General Hospital

PUBLICATIONS/ARTICLES